Abas M. Combining active ingredients to treat depression in the wake of COVID-19. Lancet Psychiatry 2022; 9: 190–91—A declaration of interests statement has been added to this Comment. This correction has been made to the online version as of Feb 17, 2022.
. 2022 Feb 17;9(3):e10. doi: 10.1016/S2215-0366(22)00038-4
Correction to Lancet Psychiatry 2022; 9: 190–91
Issue date 2022 Mar.
Crown Copyright © 2022 Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8853670 PMID: 35183283
This corrects the article "Combining active ingredients to treat depression in the wake of COVID-19" on page 190.